TY - JOUR
T1 - Identification of coagulation gene 3′UTR variants that are potentially regulated by microRNAs
AU - Vossen, Carla Y.
AU - van Hylckama Vlieg, Astrid
AU - Teruel-Montoya, Raúl
AU - Salloum-Asfar, Salam
AU - de Haan, Hugoline
AU - Corral, Javier
AU - Reitsma, Pieter
AU - Koeleman, Bobby P.C.
AU - Martínez, Constantino
N1 - Publisher Copyright:
© 2017 John Wiley & Sons Ltd
PY - 2017/6
Y1 - 2017/6
N2 - MicroRNAs have been recognized as critical regulators of gene expression and might affect the risk of venous thrombosis. We aimed to identify 3′ untranslated region (UTR) variants in coagulation genes that influence coagulation factor levels and venous thrombosis risk. The 3′UTR of coagulation genes were sequenced in subjects with extremely high or low plasma levels of these factors in two case-control studies. In total, 28 variants were identified. Five single nucleotide polymorphisms (SNPs) were predominantly present in one extreme level group (F2 rs1799963, F8 rs1050705 and F11 rs4253429, rs4253430 and rs1062547). Additional to F2 rs1799963, F8 rs1050705 (in men) and F11 rs4253430 were associated with an increased risk of venous thrombosis albeit confidence intervals were wide. The three F11 SNPs were in high linkage disequilibrium with functional variants rs2289252 and rs2036914. Rs1062547 and rs4253430 were associated with a significant increase of plasma FXI activity in heterozygotes and homozygotes in wild-type controls. In silico prediction revealed that these SNPs might disturb the binding sites of miR-544 and miR-513a-3p. Only miR-544 provoked a significant decrease of the luciferase activity that was not observed with a rs4253430 mutated vector. In conclusion, these results reinforce that microRNAs are candidates to play a role in haemostasis and complex disorders, such as thrombosis.
AB - MicroRNAs have been recognized as critical regulators of gene expression and might affect the risk of venous thrombosis. We aimed to identify 3′ untranslated region (UTR) variants in coagulation genes that influence coagulation factor levels and venous thrombosis risk. The 3′UTR of coagulation genes were sequenced in subjects with extremely high or low plasma levels of these factors in two case-control studies. In total, 28 variants were identified. Five single nucleotide polymorphisms (SNPs) were predominantly present in one extreme level group (F2 rs1799963, F8 rs1050705 and F11 rs4253429, rs4253430 and rs1062547). Additional to F2 rs1799963, F8 rs1050705 (in men) and F11 rs4253430 were associated with an increased risk of venous thrombosis albeit confidence intervals were wide. The three F11 SNPs were in high linkage disequilibrium with functional variants rs2289252 and rs2036914. Rs1062547 and rs4253430 were associated with a significant increase of plasma FXI activity in heterozygotes and homozygotes in wild-type controls. In silico prediction revealed that these SNPs might disturb the binding sites of miR-544 and miR-513a-3p. Only miR-544 provoked a significant decrease of the luciferase activity that was not observed with a rs4253430 mutated vector. In conclusion, these results reinforce that microRNAs are candidates to play a role in haemostasis and complex disorders, such as thrombosis.
KW - 3′UTR
KW - blood coagulation
KW - DNA sequencing
KW - microRNAs
KW - thrombosis
UR - http://www.scopus.com/inward/record.url?scp=85018710894&partnerID=8YFLogxK
U2 - 10.1111/bjh.14629
DO - 10.1111/bjh.14629
M3 - Article
C2 - 28444748
AN - SCOPUS:85018710894
SN - 0007-1048
VL - 177
SP - 782
EP - 790
JO - British Journal of Haematology
JF - British Journal of Haematology
IS - 5
ER -